0001127602-17-016749.txt : 20170503
0001127602-17-016749.hdr.sgml : 20170503
20170503204633
ACCESSION NUMBER: 0001127602-17-016749
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170501
FILED AS OF DATE: 20170503
DATE AS OF CHANGE: 20170503
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMGEN INC
CENTRAL INDEX KEY: 0000318154
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 953540776
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
BUSINESS PHONE: (805)447-1000
MAIL ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
FORMER COMPANY:
FORMER CONFORMED NAME: AMGEN
DATE OF NAME CHANGE: 19870305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Graham Jonathan P
CENTRAL INDEX KEY: 0001365306
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37702
FILM NUMBER: 17811426
MAIL ADDRESS:
STREET 1: 2099 PENNSYLVANIA AVENUE, NW
STREET 2: 12TH FLOOR
CITY: WASHINGTON
STATE: DC
ZIP: 20006
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2017-05-01
0000318154
AMGEN INC
AMGN
0001365306
Graham Jonathan P
ONE AMGEN CENTER DRIVE
THOUSAND OAKS
CA
91320-1799
1
SVP, Gen. Counsel & Secy.
Common Stock
2017-05-01
4
A
0
3075
0
A
50619
D
Nqso (Right to Buy)
162.60
2017-05-01
4
A
0
27233
0
A
2019-05-01
2027-05-01
Common Stock
27233
27233
D
The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three installments of 33%, 33% and 34% on 5/1/2019, 5/1/2020 and 5/1/2021, respectively.
These shares include the following RSUs granted under the Company's equity plans: 36,900 RSUs which vest in three equal installments of 12,300 on 8/4/2017, 8/4/2018 and 8/4/2019; 2,942 RSUs which vest in three installments of 970 on 5/3/2018, 971 on 5/3/2019 and 1,001 on 5/3/2020; and 3,075 RSUs which vest in installments of 1,014 on 5/1/2019, 1,015 on 5/1/2020 and 1,046 on 5/1/2021. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
These shares include 1,684 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/1/2019, 5/13/2020 and 5/1/2021, respectively.
/s/ Jonathan P. Graham
2017-05-03